Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chabot

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2017
Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant TherapyMichael D Kluger, M Farzan Rashid, Vilma L Rosario, et al.
World Journal of Surgery|December 6, 2013
Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancerIrene Epelboym, J DiNorcia, M Winner, et al.
Annals of Surgical Oncology|December 31, 2015
Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 PatientsMichael D Kluger, Irene Epelboym, Beth A Schrope, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 12, 2013
Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survivalIrmina Gawlas, Irene Epelboym, Megan Winner, et al.
Annals of Surgical Oncology|May 9, 2019
50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution ExperienceAllison S Letica-Kriegel, Joshua C Leinwand, Joshua R Sonett, et al.
Surgery|November 17, 2016
Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidismJames Y Lim, Max C Herman, Lev Bubis, et al.
Histopathology|August 15, 2015
Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesotheliomaAlyssa M Krasinskas, Alain C Borczuk, Douglas J Hartman, et al.
Annals of Surgical Oncology|October 14, 2017
Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal ChemotherapyDanielle R Heller, Cody Chiuzan, Robert N Taub, et al.
American Journal of Clinical Oncology|April 1, 2008
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesotheliomaMary E Hesdorffer, John A Chabot, Mary Louise Keohan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesotheliomaAlain C Borczuk, Robert N Taub, Mary Hesdorffer, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2017
Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant TherapyMichael D Kluger, M Farzan Rashid, Vilma L Rosario, et al.
World Journal of Surgery|December 6, 2013
Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancerIrene Epelboym, J DiNorcia, M Winner, et al.
Annals of Surgical Oncology|December 31, 2015
Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 PatientsMichael D Kluger, Irene Epelboym, Beth A Schrope, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 12, 2013
Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survivalIrmina Gawlas, Irene Epelboym, Megan Winner, et al.
Annals of Surgical Oncology|May 9, 2019
50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution ExperienceAllison S Letica-Kriegel, Joshua C Leinwand, Joshua R Sonett, et al.
Surgery|November 17, 2016
Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidismJames Y Lim, Max C Herman, Lev Bubis, et al.
Histopathology|August 15, 2015
Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesotheliomaAlyssa M Krasinskas, Alain C Borczuk, Douglas J Hartman, et al.
Annals of Surgical Oncology|October 14, 2017
Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal ChemotherapyDanielle R Heller, Cody Chiuzan, Robert N Taub, et al.
American Journal of Clinical Oncology|April 1, 2008
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesotheliomaMary E Hesdorffer, John A Chabot, Mary Louise Keohan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesotheliomaAlain C Borczuk, Robert N Taub, Mary Hesdorffer, et al.
Pageof 13